SCHEMBL2941282

SCHEMBL2941282

Nc1ccc(Oc2ccc(O)cc2)c(O)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
ESR1 P03372 1/20 0.48
ESR2 Q92731 1/20 0.48
TAAR5 O14804 1/20 0.47
TAAR1 Q96RJ0 1/20 0.47
ALDH1A1 P00352 2/20 0.44
CYP3A4 P08684 2/20 0.44
CA3 P07451 1/20 0.44
THRB P10828 1/20 0.44
ALOX15 P16050 1/20 0.44
CA6 P23280 1/20 0.44
CASP1 P29466 1/20 0.44
HIF1A Q16665 1/20 0.44
HSD17B10 Q99714 1/20 0.44
CA14 Q9ULX7 1/20 0.44
TTR P02766 1/20 0.43
TSHR P16473 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
PNLIP P16233 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6807411 0.92 ALDH1A1 (0.52) MEN1KMT2AALDH1A1CYP3A4TTR
SCHEMBL712623 0.85 CYP3A4 (0.41) MEN1KMT2AALDH1A1CYP3A4ALOX15
SCHEMBL31510866 0.85 CYP3A4 (0.41) MEN1KMT2AALDH1A1CYP3A4ALOX15
SCHEMBL7024360 0.85 ALDH1A1 (0.50) MEN1KMT2AESR1ESR2TAAR5
SCHEMBL5548962 0.85 TTR (0.61) MEN1KMT2ACYP3A4TTR
SCHEMBL676467 0.84 MEN1 (0.56) MEN1KMT2AESR1ESR2TAAR5
SCHEMBL1347657 0.83 CASP1 (0.50) MEN1KMT2AESR2ALDH1A1CYP3A4
SCHEMBL28572686 0.81 TAAR5 (0.65) MEN1KMT2AESR1ESR2TAAR5
SCHEMBL13683235 0.81 PDE10A (0.47) MEN1KMT2AESR1ESR2TAAR5
SCHEMBL10703684 0.81 PDE7A (0.53) MEN1KMT2AESR1ESR2TAAR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4505332-B2 2010-07-21 JP claimed
US-20060120957-A1 Radioactive transition metal-imido hetero-diphosphine complexes, their preparation and radiopharmaceutical compositions thereof BRACCO IMAGING S.P.A. (IT) 2006-06-08 US claimed
EP-1560602-B1 RADIOACTIVE TRANSITION METAL-IMIDO HETERO-DIPHOSPHINE COMPLEXES, THEIR PREPARATION AND RADIOPHARMACEUTICAL COMPOSITIONS THEREOF BRACCO IMAGING SPA (IT) 2006-04-12 EP claimed
JP-2006505599-A 2006-02-16 JP claimed
EP-1560602-A1 RADIOACTIVE TRANSITION METAL-IMIDO HETERO-DIPHOSPHINE COMPLEXES, THEIR PREPARATION AND RADIOPHARMACEUTICAL COMPOSITIONS THEREOF Bracco Imaging S.p.A. (IT) 2005-08-10 EP claimed
WO-2004041311-A1 RADIOACTIVE TRANSITION METAL-IMIDO HETERO-DIPHOSPHINE COMPLEXES, THEIR PREPARATION AND RADIOPHARMACEUTICAL COMPOSITIONS THEREOF BRACCO IMAGING S.P.A. (IT) 2004-05-21 WO claimed
EP-1417977-A1 Radioactive transition metal-imido hetero-diphosphine complexes, their preparation and radiopharmaceutical compositions thereof BRACCO IMAGING S.p.A. (IT) 2004-05-12 EP claimed
US-7771704-B2 Radioactive transition metal-imido hetero-diphosphine complexes, their preparation and radiopharmaceutical compositions thereof BRACCO IMAGING S.P.A. (IT) 2010-08-10 US disclosed
US-20080267869-A1 RADIOACTIVE TRANSITION METAL-IMIDO HETERO-DIPHOSPHINE COMPLEXES, THEIR PREPARATION AND RADIOPHARMACEUTICAL COMPOSITIONS THEREOF BRACCO IMAGING S.P.A. (IT) 2008-10-30 US disclosed
US-20060120957-A1 Radioactive transition metal-imido hetero-diphosphine complexes, their preparation and radiopharmaceutical compositions thereof BRACCO IMAGING S.P.A. (IT) 2006-06-08 US disclosed
EP-1560602-B1 RADIOACTIVE TRANSITION METAL-IMIDO HETERO-DIPHOSPHINE COMPLEXES, THEIR PREPARATION AND RADIOPHARMACEUTICAL COMPOSITIONS THEREOF BRACCO IMAGING SPA (IT) 2006-04-12 EP disclosed
EP-1560602-A1 RADIOACTIVE TRANSITION METAL-IMIDO HETERO-DIPHOSPHINE COMPLEXES, THEIR PREPARATION AND RADIOPHARMACEUTICAL COMPOSITIONS THEREOF Bracco Imaging S.p.A. (IT) 2005-08-10 EP disclosed
WO-2004041311-A1 RADIOACTIVE TRANSITION METAL-IMIDO HETERO-DIPHOSPHINE COMPLEXES, THEIR PREPARATION AND RADIOPHARMACEUTICAL COMPOSITIONS THEREOF BRACCO IMAGING S.P.A. (IT) 2004-05-21 WO disclosed
EP-1417977-A1 Radioactive transition metal-imido hetero-diphosphine complexes, their preparation and radiopharmaceutical compositions thereof BRACCO IMAGING S.p.A. (IT) 2004-05-12 EP disclosed
EP-0921116-B1 N-(4-carbamimido-phenyl)-glycine amide derivatives HOFFMANN LA ROCHE (CH) 2003-06-18 EP disclosed
US-6140353-A USED AS MEDICAMENTS FOR THE TREATMENT AND/OR PREVENTION OF THROMBOSES, APOPLEXY, CARDIAC INFARCTION, INFLAMMATION AND ARTERIOSCLEROSIS OR AS ANTITUMOR AGENTS HOFFMANN-LA ROCHE INC. (US) 2000-10-31 US disclosed
EP-0921116-A1 N-(4-carbamimido-phenyl)-glycine amide derivatives F. HOFFMANN-LA ROCHE AG (CH) 1999-06-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080267869-A1 RADIOACTIVE TRANSITION METAL-IMIDO HETERO-DIPHOSPHINE COMPLEXES, THEIR PREPARATION AND RADIOPHARMACEUTICAL COMPOSITIONS THEREOF MEN1, IGF2R, RABL3 MEN1 1/4885KMT2A 2640/4885ESR1 1673/4885
US-20060120957-A1 Radioactive transition metal-imido hetero-diphosphine complexes, their preparation and radiopharmaceutical compositions thereof RABL3, RABL6, IGF2R MEN1 6/4885KMT2A 2286/4885ESR1 1818/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.